Abstract: Provided are peptide biomarkers for diagnosis of allergy, monitoring development of clinical tolerance in an allergic individual, and predicting whether an allergic subject is likely to develop clinical or natural tolerance over time. The invention also relates to diagnostic methods and diagnostic kits employing the peptide biomarkers.
Type:
Grant
Filed:
November 29, 2021
Date of Patent:
February 10, 2026
Assignees:
AllerGenis, Inc., ICAHN School of Medicine at Mount Sinai
Inventors:
Robert C. Getts, James Kadushin, Hugh A. Sampson, Ludmilla Bardina, Galina Grishina, Gustavo Gimenez, Jing LIn